PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L ® in Clinical Practice: An Expert Discussion with Prof Nicolas van Mieghem
Up Next
-
26sPart 2 | Session 1 Introduction
-
4m 29sPart 2 | Session 2 MCS indications and patient selection
-
4m 10sPart 2 | Session 3 Overview: Percutaneous MCS Systems
-
3m 44s
-
2m 50sPart 2 | Session 5 Patient screening and access site management
-
4m 9sPart 2 | Session 6 iVAC 2L ® technology overview, procedure, technique and performance
-
3m 6sPart 2 | Session 7 Summary: iVAC 2L ® and Mechanical Unloading
-
5m 5sPart 2 | Session 8 Study Design and Population
-
3m 45sPart 2 | Session 9 Key Findings
-
1m 18sPart 2 | Session 10 iVAC 2L ® effects on Cardiac Mechanics
-
1m 10sPart 2 | Session 11 Pulse Trial Conclusion
-
4m 57sPart 2 | Session 12 Frequently Asked Questions
-
2m 18sPart 3 iVAC 2L ® - pVAD
-
18m 41sPart 4 | Session 1 Pulsatile LV support during high-risk PCI (the PulseCath iVAC 2L)
-
10m 6sPart 4 | Session 2 The concept of pulsatile LV support (the PulseCath iVAC 2L)
-
9m 48sPart 4 | Session 3 Pulsatile vs. Continuous percutaneous MCS
-
23m 24sPart 4 | Session 4 Large bore access - basic concepts
-
3m 28s
-
19m 12sPart 6 | Session 2 Prof Joško Bulum presents his experience with the iVAC 2L
-
10m 30s
About the episode
iVAC 2L experience from University Hospital of Bellvitge, Barcelona, ES
Overview
In this video series, Professor Nicolas van Mieghem will discuss the benefits of iVAC 2L ® in clinical practice and will share the learnings and key outcomes from the Pulse Trial, and the effect of next generation pulsatile mechanical circulatory support (MCS).
This video is supported by PulseCath in collaboration with their co-sponsors: CardiRad, Sanomed, LeviBio, Thomy F.E., Sonimed and Dot Medical.
This video series is sponsored by:
Key Learning Objectives
- Learn when to use the short term percutaneous ventricular assist device (pVAD), iVAC 2L ® in clinical practice
- Understand the differences between pulsatile and continuous flow
- Understand the technology behind the device
- Gain a better understanding of how the iVAC 2L ® is more efficient
- Learn how to identify the right patient (HR PCI)
- Learn when to use iVAC 2L ® vs Impella
- Further understanding of large bore access management
Target Audience
- Interventional Cardiologists
- Cardiac Surgeons
- Cardiac Nurses
- Cath Lab Nurses
- ICU Doctors
- Perfusionists
- Cath Lab Technicians
More from this programme
Part 1
Full Programme - PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L ® in Clinical Practice: An Expert Discussion with Prof Nicolas van Mieghem
Part 2
Chapters of Programme - PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L ® in Clinical Practice: An Expert Discussion with Prof Nicolas van Mieghem
Part 3
iVAC 2L ® - pVAD procedure
| 1 session | |
| Watch now |
Part 4
Pulsatile LV support during high-risk PCI
Part 5
iVAC 2L experience from CINRE hospital – Bratislava - Slovakia
Part 6
iVAC 2L experience from University Hospital Centre Zagreb, Zagreb, HR
Part 7
Procedure IVAC 2L in high risk PCI University Hospital of Bellvitge, Barcelona, (Spanish)
Dr Joan Antoni Gomez-Hospital (University Hospital of Bellvitge, Barcelona, ES) shares his experience on the iVAC 2L and the practical issues.
Part 8
